RNA Structure Modulates Splicing Efficiency at the Human Immunodeficiency Virus Type 1 Major Splice Donor

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2007 Dec 28

PMID 18160437

Citations 54

Authors

Truus E M Abbink

Ben Berkhout

Affiliations

Soon will be listed here.

Abstract

The untranslated leader of the human immunodeficiency virus type 1 (HIV-1) RNA genome encodes essential sequence and structural motifs that control various replication steps. The 5' splice site or splice donor (SD) is embedded in a semistable hairpin, but the function of this structure is unknown. We stabilized this SD hairpin by creating an additional base pair and demonstrated a severe HIV-1 replication defect. A splicing defect was apparent in RNA analyses of virus-infected cells and cells transfected with appropriate reporter constructs. We selected multiple virus revertants in search for interesting second-site escape pathways. Most revertants acquired an additional mutation that modulated the stability of the mutant SD hairpin. One revertant acquired a single nucleotide change in the upstream DIS hairpin. We demonstrate that a novel SD site is created by this upstream mutation, which obviously reduces the number of leader nucleotides that are included in spliced HIV-1 transcripts. These results suggest a novel role of RNA structure in the regulation of HIV-1 splicing.

Citing Articles

Host RNA-Binding Proteins as Regulators of HIV-1 Replication.

Giraldo-Ocampo S, Valiente-Echeverria F, Soto-Rifo R Viruses. 2025; 17(1).

PMID: 39861832 PMC: 11768693. DOI: 10.3390/v17010043.

Role of RNA structural plasticity in modulating HIV-1 genome packaging and translation.

Yasin S, Lesko S, Kharytonchyk S, Brown J, Chaudry I, Geleta S Proc Natl Acad Sci U S A. 2024; 121(33):e2407400121.

PMID: 39110735 PMC: 11331132. DOI: 10.1073/pnas.2407400121.

HIV co-opts a cellular antiviral mechanism, activation of stress kinase PKR by its RNA, to enable splicing of rev/tat mRNA.

Namer L, Harwig A, Heynen S, Das A, Berkhout B, Kaempfer R Cell Biosci. 2023; 13(1):28.

PMID: 36774495 PMC: 9922466. DOI: 10.1186/s13578-023-00972-1.

Sequestering the 5'-cap for viral RNA packaging.

Ding P, Summers M Bioessays. 2022; 44(11):e2200104.

PMID: 36101513 PMC: 10201543. DOI: 10.1002/bies.202200104.

HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.

Crespo R, Rao S, Mahmoudi T Front Cell Infect Microbiol. 2022; 12:855092.

PMID: 35774399 PMC: 9237370. DOI: 10.3389/fcimb.2022.855092.

References

Klaver B, Berkhout B . Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 1994; 13(11):2650-9. PMC: 395139. DOI: 10.1002/j.1460-2075.1994.tb06555.x. View

Klaver B, Berkhout B . Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol. 1994; 68(6):3830-40. PMC: 236888. DOI: 10.1128/JVI.68.6.3830-3840.1994. View

Jacquenet S, Ropers D, Bilodeau P, Damier L, Mougin A, Stoltzfus C . Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucleic Acids Res. 2001; 29(2):464-78. PMC: 29680. DOI: 10.1093/nar/29.2.464. View

Huthoff H, Berkhout B . Two alternating structures of the HIV-1 leader RNA. RNA. 2001; 7(1):143-57. PMC: 1370064. DOI: 10.1017/s1355838201001881. View

Berkhout B, Das A, Beerens N . HIV-1 RNA editing, hypermutation, and error-prone reverse transcription. Science. 2001; 292(5514):7. DOI: 10.1126/science.292.5514.7a. View

Beerens N, Groot F, Berkhout B . Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem. 2001; 276(33):31247-56. DOI: 10.1074/jbc.M102441200. View

Tange T, Damgaard C, Guth S, Valcarcel J, Kjems J . The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 2001; 20(20):5748-58. PMC: 125679. DOI: 10.1093/emboj/20.20.5748. View

Beerens N, Berkhout B . The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J Virol. 2002; 76(5):2329-39. PMC: 153804. DOI: 10.1128/jvi.76.5.2329-2339.2002. View

Cartegni L, Chew S, Krainer A . Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002; 3(4):285-98. DOI: 10.1038/nrg775. View

10.

Wei X, Decker J, Liu H, Zhang Z, Arani R, Michael Kilby J . Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 2002; 46(6):1896-905. PMC: 127242. DOI: 10.1128/AAC.46.6.1896-1905.2002. View

11.

Wei X, Decker J, Wang S, Hui H, Kappes J, Wu X . Antibody neutralization and escape by HIV-1. Nature. 2003; 422(6929):307-12. DOI: 10.1038/nature01470. View

12.

Abbink T, Berkhout B . A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J Biol Chem. 2002; 278(13):11601-11. DOI: 10.1074/jbc.M210291200. View

13.

HILL M, Shehu-Xhilaga M, Campbell S, Poumbourios P, Crowe S, Mak J . The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells. J Virol. 2003; 77(15):8329-35. PMC: 165254. DOI: 10.1128/jvi.77.15.8329-8335.2003. View

14.

Domsic J, Wang Y, Mayeda A, Krainer A, Stoltzfus C . Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts. Mol Cell Biol. 2003; 23(23):8762-72. PMC: 262674. DOI: 10.1128/MCB.23.23.8762-8772.2003. View

15.

Kim S, Byrn R, Groopman J, Baltimore D . Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol. 1989; 63(9):3708-13. PMC: 250962. DOI: 10.1128/JVI.63.9.3708-3713.1989. View

16.

Daly T, Cook K, GRAY G, Maione T, Rusche J . Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature. 1989; 342(6251):816-9. DOI: 10.1038/342816a0. View

17.

BOOM R, Sol C, Salimans M, Jansen C, van der Noordaa J . Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990; 28(3):495-503. PMC: 269651. DOI: 10.1128/jcm.28.3.495-503.1990. View

18.

Schwartz S, Felber B, Benko D, Fenyo E, Pavlakis G . Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol. 1990; 64(6):2519-29. PMC: 249427. DOI: 10.1128/JVI.64.6.2519-2529.1990. View

19.

Klotman M, Kim S, Buchbinder A, Derossi A, Baltimore D, Wong-Staal F . Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A. 1991; 88(11):5011-5. PMC: 51797. DOI: 10.1073/pnas.88.11.5011. View

20.

Purcell D, Martin M . Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol. 1993; 67(11):6365-78. PMC: 238071. DOI: 10.1128/JVI.67.11.6365-6378.1993. View